Showing 49 - 72 of 142 results
Previous| 1... 2 | 3 | 4 ...6 |Next
Psychedelic Treatment with Psilocybin Relieves Major Depression
Psychedelic Treatment with Psilocybin Relieves Major Depression, Study Shows
Psychiatry Grand Rounds: “What is COVID Depression?”
Achieving 'Balance': How a Johns Hopkins Program Boosts Corporate Mental Health
Diversity by Race, Ethnicity, and Sex within the US Psychiatry Physician Workforce
‘New Terrain’: Psychiatrist Opens Up About Caring for Patients Recovering from COVID-19
Treating Substance Use Disorder During COVID-19
Gene Reveals Itself As Key Epigenetic Regulator in Neurodevelopmental Disorders
First-of-Its Kind Psychedelic Research Center Debuts at Johns Hopkins
Genetic Syndrome of Intellectual Disability Fixed in Mice Using Precision Epigenome Editing
Bob Roca's Back-to-the-Future Moment
Why Defining Impulsive/Reactive Aggression in Youth Matters
Using Big Data to Decode Alzheimer’s Disease
Telemedicine Keeps Young Patients Connected to Psychiatric Care
Some CBD Products May Yield Cannabis-Positive Urine Drug Tests
Lab Studies Dive Headfirst into Pathways Touched by Schizophrenia
Low-Cost Intervention Reduces Risk of Opioid Overdose
Esketamine: A New Approach for Patients with Treatment-Resistant Depression
Johns Hopkins Launches Center For Psychedelic Research
High Fat Diet During Pregnancy Slows Learning in Offspring, Rat Study Suggests
Deep Brain Stimulation Eases Parkinson’s Disease Symptoms by Boosting Dopamine
‘Stressors’ In Middle Age Linked To Cognitive Decline In Older Women
#TomorrowsDiscoveries: A Different Approach to Treating Psychiatric Disorders
Support for Patients with Mood Disorders Between Visits, Thanks to an App